Healthcare & Biotech

London – September 19, 2026 -- Business Worldwide Magazine has named MyPureSkin S.A, a Swiss nutricosmetics company, to its list of the 20 Most Innovative Healthcare Companies to Watch in 2026.

Swiss firm builds clinically validated skin-health platform from Health Valley base

Founded by Edgar Brandt and Tatiana Brandt in Switzerland's Health Valley, MyPureSkin operates on the premise that skin should receive the same nutritional and scientific attention as other organs. The company now sells across Europe, North America, the Middle East, and Australia.

Proprietary Nutrigevity framework anchors product development

MyPureSkin's formulations are built around NutrigevityTM, a proprietary framework targeting three biological pillars: Structure, Signalling, and Regeneration. The framework draws on expertise from clinical medicine, plastic surgery, gynaecology, micronutrition, and skin biology.

New Delhi – September 19, 2026 -- Apollo Athenaa Women's Cancer Centre has treated more than 30,000 women from over 110 cities and performed 1,000-plus cancer surgeries in its first year of operation, marking its anniversary as Asia's first dedicated cancer centre for women.

Centre completes 4,000+ chemotherapy cycles and 100+ reconstruction procedures in year one

Apollo Athenaa's clinical volumes in its debut year include over 4,000 chemotherapy cycles, more than 100 plastic and breast reconstruction procedures, and 120-plus VABB (vacuum-assisted breast biopsy) procedures. The centre built an integrated care model spanning breast and gynaecological oncology, reconstruction, medical and precision oncology, diagnostics and rehabilitation.

Pleasanton, Calif. – September 19, 2026 -- Healthcare Triangle, Inc. (Nasdaq: HCTI) has signed on as the U.S. technology and capital-markets partner for the newly launched Kanzun-ARCB Growth Fund, a vehicle designed to move Malaysian healthcare companies toward Middle Eastern capital and, ultimately, U.S. capital markets.

ARCB and Kanzun formalize the fund via a Kuala Lumpur MOU

The Kanzun-ARCB Growth Fund launched through a Memorandum of Understanding signed in Kuala Lumpur, pairing Dubai-based ARCB Investment LLC's capital network with Kanzun Ventures Management Sdn. Bhd.'s deal execution in Malaysia. ARCB opened its Asia-Pacific office in Kuala Lumpur in April 2026, and this fund represents its first major platform launch in the region.

Lafayette, Ind. – September 19, 2026 -- Valley Oaks Health has secured $828,375 through the Growing Rural Opportunities for Well-being (GROW) Region 3 Grant to expand integrated healthcare access across rural northwest central Indiana.

Funding stems from a $206.9 million federal transformation program

The award is part of the Indiana Rural Health Transformation Program (Indiana RHTP), a statewide initiative fully funded by the Centers for Medicare & Medicaid Services (CMS) under a financial assistance award totaling $206,927,896.80. CMS/HHS covers 100 percent of the program, which spans five years and targets healthcare infrastructure, workforce development, and regional collaboration.

Henderson, Nev. – September 19, 2026 -- PDS Health provided $22.8 million in donated dental services to 5,863 patients nationwide during its 16th annual Smile Generation Serve Day, held throughout August.

More than 14,000 team members logged 83,549 volunteer hours in one month

The integrated healthcare support organization mobilized over 14,000 staff members across its network of affiliated practices to deliver free treatment to individuals facing barriers to dental care. Since the initiative launched in 2011, cumulative donated care has reached more than $117 million.

Houston – September 19, 2026 -- Octagos has been named to TIME and Statista's World's Top HealthTech Companies of 2026 list, marking the only cardiac implantable electronic device (CIED) monitoring company recognized in either the inaugural 2025 ranking or the 2026 edition.

TIME and Statista rank Octagos among 82 AI and Data Analytics firms out of 500 global honorees

The evaluation weighted financial performance at 50%, reputation at 30%, and online engagement at 20%. Octagos received a "Very High" performance rating within the AI and Data Analytics category, one of six categories spanning the 500-company list.

Scottsdale, Ariz. – September 19, 2026 -- CND Life Sciences, Inc. has opened a new Innovation Laboratory in Scottsdale, Arizona, expanding its research and product-development capacity for neurodegenerative disease diagnostics. The facility was inaugurated with a ribbon-cutting ceremony attended by employees, community members, and key stakeholders, and operations are set to begin next week.

New facility separates R&D from clinical testing operations

The Innovation Laboratory operates independently from CND's existing CLIA-certified, CAP-accredited, and CLEP-permitted clinical laboratory, which processes the company's Syn-One Test. The new space is dedicated to assay development, biomarker research, technology evaluation, and translational research programs, allowing the company to pursue early-stage science without disrupting clinical throughput.

Paris – September 19, 2026 -- Virbac posted first-half 2026 revenue growth of 7.4% at constant exchange rates and currencies (CERS), lifting its adjusted EBIT margin to 18.8%, up 0.5 percentage points from H1 2025.

Companion animal segment leads growth at 10.0%, farm animal follows at 6.7%

The animal health group's Supercharge platforms, excluding Thyronorm, expanded around 12% at CERS, becoming a key driver of top-line performance. Growth split into a volume/mix effect of approximately 5.4% and a price increase of roughly 2%.

Net income climbs 5.9% to €87.1 million

The margin gain stemmed from a favorable gross margin mix, partially offset by higher operating expenses tied to H1/H2 phasing effects.

London – September 19, 2026 -- UK biotech spin-out Eterna Regeneratives has closed a seed funding round led by Hoxton Ventures and The Venture Collective to commercialize a keratin-based material that regrows tooth enamel, targeting the $43 billion global oral care market.

King's College London spin-out moves from lab to commercial pipeline

Co-founded in 2024 by Khaled Eissa and Dr Sherif Elsharkawy, Eterna emerged from research led by Elsharkawy and PhD student Dr Sara Gamea that drew coverage from the BBC, Washington Post and Newsweek after demonstrating keratin's capacity to regrow damaged enamel. The seed round funds the shift from proof-of-concept research to real-world product development, according to Elsharkawy, the company's Chief Scientific Officer.

New York – September 19, 2026 -- DarioHealth Corp. (NASDAQ: DRIO) has secured a new contract with one of New Jersey's largest health plans, covering approximately 1.5 million lives, through its channel partnership with Amwell. The program covering Dario's cardiometabolic suite and provider-backed care is expected to launch and begin generating revenue in the first quarter of 2027.

Amwell channel delivers third major state health plan in 12 months

The New Jersey deal follows previously secured contracts with major health insurers in Arizona and Florida, marking the third large state health plan Dario has signed through Amwell within the past year. The customer operates as an administrative services only (ASO) health plan, giving Dario access to a broad population of self-funded employer groups eligible to deploy its cardiometabolic solutions.